Rapporto sull’analisi delle dimensioni del mercato e delle quote della gastroparesi | Previsioni 2031

  • Report Code : TIPRE00008992
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 155
Buy Now

[Rapporto di ricerca] Il mercato della gastroparesi è stato valutato a 4.338,61 milioni di dollari nel 2019 e si prevede che raggiungerà 6.025,11 milioni di dollari entro il 2027; si prevede che crescerà a un CAGR del 4,3% dal 2020 al 2027.

La gastroparesi è una condizione medica caratterizzata dall'incapacità dello stomaco di svuotarsi del cibo nel modo consueto. Anche i nervi danneggiati come i nervi vaghi e i muscoli associati alla motilità gastrica possono portare alla gastroparesi. La condizione è comunemente osservata nelle persone diabetiche. La gastroparesi può essere classificata in diabetica, idiopatica e post-operatoria in base alla causa. Oltre a questi, anche le infezioni virali, le malattie legate ai nervi, il consumo eccessivo di narcotici e di diversi antidepressivi e l'amiloidosi possono portare all'insorgenza della gastroparesi.

Il COVID-19 La pandemia ha interrotto la catena di fornitura dei farmaci da banco (OTC) e da prescrizione e ciò limiterà probabilmente la crescita del mercato nei prossimi trimestri. Inoltre, l'enfasi degli operatori sanitari e delle industrie mediche sul COVID-19 ha portato a una minore attenzione alla diagnosi e al trattamento della gastroparesi, il che sta limitando in una certa misura la crescita del mercato.

 < /p>

Regioni redditizie per il mercato della gastroparesi


Approfondimenti sul mercato

Aumento della popolazione geriatrica che accelera la domanda di gastroparesi Modalità di trattamento

Lo svuotamento gastrico è associato alla coordinazione tra l'attività motoria dello stomaco prossimale, dello stomaco distale e del duodeno. Questi organi interni sono controllati dal meccanismo di feedback dei segnali neurali generati attraverso l'interazione tra nutrienti e intestino tenue. L’invecchiamento porta ad una diminuzione della regolazione omeostatica delle funzioni fisiologiche, insieme al rallentamento dello svuotamento gastrico. Inoltre, influenza le funzioni motorie e sensoriali. Inoltre, la popolazione geriatrica è altamente vulnerabile alla gastroparesi a causa di fattori quali lo scarso assorbimento dei farmaci per via orale, l’inadeguata regolazione dell’appetito e la glicemia postprandiale. Secondo la revisione del 2019 del World Population Prospects, 1 persona su 6 avrebbe più di 65 anni entro il 2050, con un aumento rispetto a 1 su 11 nel 2019. Inoltre, secondo lo stesso studio, una persona su quattro in Europa e Nord America si prevede che avranno più di 65 anni entro il 2050. Inoltre, il numero di persone con più di 80 anni raggiungerà i 426 milioni entro il 2050 rispetto ai 143 milioni del 2019. Pertanto, il continuo aumento dell'invecchiamento della popolazione, unito all'aumento dei problemi associati all'età lo svuotamento gastrico tra queste popolazioni, guida la crescita del mercato della gastroparesi.

Approfondimenti basati sul tipo

Sulla base del tipo, il mercato della gastroparesi è segmentato in idiopatico, diabetico, post-chirurgico e altri. Il segmento idiopatico ha detenuto la quota maggiore del mercato nel 2019, mentre si stima che il segmento diabetico registrerà il CAGR più elevato durante il periodo di previsione.

Mercato della gastroparesi, per tipo – 2019 e 2027

Approfondimenti basati sul tipo di classe di farmaci

Il mercato della gastroparesi, basato sul tipo di classe di farmaci, è segmentato in agenti procinetici, agenti antiemetici e iniezioni di tossina botulinica. Il segmento degli agenti procinetici ha detenuto la quota di mercato maggiore nel 2019 e si stima che registrerà il CAGR più elevato nel corso del 2020-2027.

Approfondimenti basati sui canali di distribuzione

< p> Sulla base del canale di distribuzione, il mercato della gastroparesi è segmentato in farmacie ospedaliere, farmacie al dettaglio e altri. Il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato nel 2019 e si stima che il mercato per lo stesso crescerà al CAGR più elevato dal 2020 al 2027.

Strategico Approfondimenti

Gli attori del mercato della gastroparesi hanno adottato la strategia delle innovazioni di prodotto per soddisfare le richieste dinamiche dei clienti, che consente loro anche di mantenere il proprio marchio nel mercato globale.

Mercato della gastroparesi: per tipo

  • Idiopatico
  • Diabetico
  • Post-chirurgico
  • Altro

Mercato della gastroparesi: per tipo di classe di farmaco

  • Agenti procinetici
  • Iniezioni di tossina botulinica
  • Agenti antiemetici

Mercato della gastroparesi - per canale di distribuzione

  • Farmacie ospedaliere
  • Farmacie al dettaglio
  • Altro

Mercato della gastroparesi– per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'area APAC
  • Medio Oriente e Africa (MEA)
    • Sud Africa
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del MEA
  • Sud America e America Centrale (SCAM )
    • Brasile
    • Argentina
    • Resto di SCAM

 

Profili aziendali

  • EVOKE PHARMA
  • Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  • Johnson and Johnson Services, Inc
  • Allergan Plc
  • NEUROGASTRX, INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Pfizer Inc.
  • ANI Pharmaceuticals, Inc.
  • Ipca Laboratories Ltd.
  • Cinrx Pharma, LLC (Cindome Pharma)
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is gastroparesis?

Gastroparesis is a condition where the stomach cannot empty itself of food in the usual way. Moreover, the damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is substantially observed in the diabetic population. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of causes. Apart from these viral infections, nerve-related diseases, excessive consumption of narcotics and some antidepressants, and amyloidosis may also lead to the occurrence of gastroparesis.

What are the driving factors for the gastroparesis market across the globe?

The growth of the market is attributed to some key driving factors such as increasing prevalence of diabetes and growing geriatric population.

Who are the major players in the gastroparesis market?

The gastroparesis market majorly consists of the players such as EVOKE PHARMA, Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., And Cinrx Pharma, LLC (Cindome Pharma) amongst others.

The List of Companies - Gastroparesis Market

  1. EVOKE PHARMA
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Johnson and Johnson Services, Inc.
  4. Allergan Plc
  5. NEUROGASTRX, INC.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD
  7. Pfizer Inc.
  8. ANI Pharmaceuticals, Inc.
  9. Ipca Laboratories Ltd.
  10. Cinrx Pharma, LLC (Cindome Pharma)  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports